NCT00523250 - Ocular Hypotensive Efficacy of AR-102 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Glaucoma

Interventions

DRUG

AR-102 0.003% Ophthalmic Solution

DRUG

AR-102 0.005% Ophthalmic Solution

DRUG

AR-102 0.01% Ophthalmic Solution

DRUG

AR-102 0.03% Ophthalmic Solution

DRUG

AR-102 Vehicle Ophthalmic Solution

Trial Locations (8)

Mundorf Practice, Charlotte

Hernando Eye Institute, Brooksville

Taustine Eye Center, Louisville

Black Hills Regional Eye Institute, Rapid City

Medical Center Ophthalmology Associates, San Antonio

Texan Eye, Austin

Soilsh Practice, Pasadena

Bacharach practice, Petaluma